| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |